Tenax Therapeutics Provides Regulatory Update on Levosimendan

Go back to Tenax Therapeutics Provides Regulatory Update on Levosimendan
(NASDAQ: TENX) Delayed: 1.72 +0.08 (4.88%)
Previous Close $1.64    52 Week High $3.40 
Open $1.62    52 Week Low $1.34 
Day High $1.76    P/E N/A 
Day Low $1.60    EPS $0.00 
Volume 1,670,461